Overview

CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II

Status:
Recruiting
Trial end date:
2028-01-01
Target enrollment:
Participant gender:
Summary
The objective of CIRCULATE trial is to improve care of patients after colon tumor surgery, based on an innovative marker: circulating tumor DNA.
Phase:
Phase 3
Details
Lead Sponsor:
Centre Hospitalier Universitaire Dijon